Oximes
Selleck Chemical LLC 2.3-Butanedione-2-monoxime S3699-1g
2 3-Butanedione monoxime (BDM Diacetyl monoxime Diacetylmonoxime) is the well-characterized low-affinity non-competitive inhibitor of skeletal muscle myosin-II and inhibits skeletal and cardiac muscle contraction
Selleck Chemical LLC Acetophenone
Acetophenone (Methyl phenyl ketone Phenylethanone) is an organic compound used as fragrances and a raw material for the synthesis of some pharmaceuticals
Selleck Chemical LLC Milbemycin Oxime S5055-25mg
Milbemycin Oxime is a broad spectrum anti-parasitic drug that is active against worms (anthelmintic) and mites (miticide)
Selleck Chemical LLC Indirubin-3-monoxime S2009-5mg
Indirubin-3 -monoxime (Indirubin-3 -oxime) is a selective CDK inhibitor with IC50 of 0 18 M 0 44 M 0 25 M 3 33 M 0 065 M for CDK1-cyclinB CDK2-cyclinA CDK2-cyclinE CDK4-cyclinD1 CDK5-p35 respectively Indirubin-3 -monoxime is a direct and selective 5-lipoxygenase inhibitor with IC50 of 7 8-10 M
Medchemexpress LLC Biacetyl monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 10g
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Medchemexpress LLC 2,3-butanedione monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 1mL
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Medchemexpress LLC Propan-2-one oxime | 127-06-0 | 99.97% | 73.09 | 100 G
Propan-2-one oxime is a type of biological material or organic compound extensively utilized in life science research. It is intended for research use only and is not sold to patients.
- Utilized in life science research.
- Used as a laboratory chemical in the manufacture of substances.
- Appears as a white to off-white solid.
- Consistent 1H NMR spectrum.
Medchemexpress LLC Biacetyl monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 1g
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Medchemexpress LLC 2,3-butanedione monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 | C4H7NO2 | 500mg
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Medchemexpress LLC 2,3-butanedione monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 5g
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Medchemexpress LLC N-hydroxy-3-pyridinecarboximidamide | 1594-58-7 | MFCD00125875 | 97.0% | 137.14 g/mol | C6H7N3O | 25 G
3-Pyridylamide oxime (N-hydroxy-3-pyridinecarboximidamide) is a small-molecule synthetic intermediate used in pharmaceutical and fine chemical synthesis. It is typically supplied as a solid reagent for building heterocyclic scaffolds and preparing downstream derivatives, and is accompanied by analytical documentation to support research use.
- High purity suitable for synthetic applications.
- Useful as a building block for heterocycle synthesis.
- Solid form enables easy handling and weighing.
- Provided with a certificate of analysis for traceability.
- Compatible with standard organic synthesis conditions.
Medchemexpress LLC 3-pyridylamide oxime | 1594-58-7 | >98.0% | 137.14 g·mol⁻¹ | C6H7N3O | 50 G
3-Pyridylamide oxime is a pyridine-derived amidoxime used as a synthetic intermediate in pharmaceutical and organic chemistry. It is provided as a solid research reagent and is used for building heterocycles, introducing amidoxime functionality, and advancing medicinal chemistry workflows.
- Chemical identity: pyridine-based amidoxime (C6H7N3O), CAS 1594-58-7.
- Molecular weight 137.14 g·mol⁻¹.
- High purity suitable for synthesis (>98% typical).
- Useful for medicinal chemistry and pharmaceutical intermediate synthesis.
- Supplied as a solid, compatible with common organic solvents.
- Available in multiple pack sizes to support small-scale and scale-up work.
Apexbio Technology LLC 2,3-Butanedione-2-monoxime 57-71-6 10mM (in 1mL DMSO)
2 3-Butanedione-2-monoxime (BDM CAS 57-71-6) is a small molecule inhibitor of myosin ATPase activity By interfering with the ATP-driven cross-bridge cycling of myosin BDM disrupts the conversion of chemical energy into mechanical force impacting cytoskeletal dynamics In vitro studies have shown that treatment with BDM in fission yeast leads to reduced cell size increased septation and altered actin organization though cytokinetic actin ring formation is maintained BDM is widely employed as a reversible probe of myosin function in muscle and cell biology research to elucidate contractile mechanisms and cytoskeletal behaviors
Apexbio Technology LLC 2,3-Butanedione-2-monoxime 57-71-6 100g
2 3-Butanedione-2-monoxime (BDM CAS 57-71-6) is a small molecule inhibitor of myosin ATPase activity By interfering with the ATP-driven cross-bridge cycling of myosin BDM disrupts the conversion of chemical energy into mechanical force impacting cytoskeletal dynamics In vitro studies have shown that treatment with BDM in fission yeast leads to reduced cell size increased septation and altered actin organization though cytokinetic actin ring formation is maintained BDM is widely employed as a reversible probe of myosin function in muscle and cell biology research to elucidate contractile mechanisms and cytoskeletal behaviors